Document is current
Any future updates will be listed below
-
Authors
Shah, Eric D. https://orcid.org/0000-0003-3611-8628
Chang, Lin
Lembo, Anthony
Staller, Kyle
Curley, Michael A.
Chey, William D.
-
Funding
Funding for this research was provided by:
AGA Research Foundation (2019 AGA-Shire Research Scholar Award in Functional GI and Motility Disorders)
- License Information
-
More Information
Article History
Received: 12 September 2020
Accepted: 22 December 2020
First Online: 12 January 2021
Compliance with Ethical Standards
:
: Dr. Chey is a consultant for Allergan, Biomerica, IM Health, Ironwood, Outpost, QOL Medical, Ritter, Salix, Urovant, and has research grants from Commonwealth Diagnostics, Ironwood, QOL Medical, Salix, Urovant, Vibrant, and Zespri. Dr. Lembo is a consultant for Allergan, Salix, Ironwood, Takeda, Bayer, and Ardelyx. Dr. Chang has served as a consultant or advisory board member of Ironwood, Allergan, Alfasigma, Shire-Takeda, IM Health Sciences, Arena Pharmaceuticals, and has been a speaker for Salix. Dr. Staller has received research support from Takeda, AstraZeneca, and Gelesis, has served as a consultant or advisor board member for Shire, Synergy, Boston Pharmaceuticals, and Arena Pharmaceuticals, and has served as a speaker for Shire. The other authors have no personal or financial disclosures.
